March 11, 2026
Earnings
Vertex's Kidney Trial Win: Progress or Peril for Biotech Bulls?
Vertex Pharmaceuticals surged 4% on rare disease trial success, but investors should weigh pipeline risks against diversification hopes.
Markets
TSX Materials Rally Outpaces US Markets as Gold Hits Record Highs
Canadian equities outperform as materials and financials drive .GSPTSE to 33,270.65 while gold surges to $5,242/oz.
Markets
While the Dow Panics, Tech Plays Defense: What the 800-Point Swing Really Tells Us
Markets shrug off geopolitical noise as tech resilience counters energy volatility. The divergence between Nasdaq gains and Dow losses signals a structural rota…
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.